## What is/are 27 Randomized?

27 Randomized - Results Of 827 randomized patients, 735 (372 fibrinogen concentrate, 363 cryoprecipitate) were treated and included in the primary analysis (median age, 64 [interquartile range, 53-72] years; 30% women; 72% underwent complex operations; 95% moderate to severe bleeding; and pretreatment fibrinogen level, 1.^{[1]}Results: 27 randomized controlled trials (RCTs) were included for analysis (7 evaluating non pharmacologic interventions, 20 pharmacologic therapies).

^{[2]}This meta-analysis included 227 randomized controlled.

^{[3]}Forty‐one of 10 132 identified records were included, comprising 6348 participants and 373 outcomes with sample sizes ranging from 10 to 833, including 27 randomized controlled trials (RCTs).

^{[4]}STUDY DESIGN Authors reported primary outcomes from 11 Cochrane systematic reviews (SRs), 12 other SRs, and 327 randomized controlled trials (RCTs).

^{[5]}A total of 27 randomized controlled trials (RCTs), involving 6924 TNBC patients, were included.

^{[6]}Results Overall, 27 randomized controlled trials (RCTs), 1 cluster RCT (cRCT), and 1 quasi-RCT were included in this review.

^{[7]}ResultsFrom 12,773 identified articles, 27 randomized clinical trials were identified.

^{[8]}RESULTS We systematically reviewed 27 randomized control trials (13,356 participants), which compared 12 different antiemetic regimens: serotonin-3 receptor antagonist (5HT3), 5HT3 + dexamethasone (Dex), palonosetron (PAL), PAL + Dex, PAL at 0.

^{[9]}40 studies (n =5411, mean age 50 to 76 y, 21% to 100% men), including 27 randomized controlled trials (RCTs), met the inclusion criteria.

^{[10]}RESULTS The literature search retrieved 27 randomized, controlled trials involving a total of 3,198 patients.

^{[11]}OUTCOMES We found twelve eligible systematic reviews which included between three (143 women) and 27 randomized trials (2093 women).

^{[12]}A systematic review and meta‐analysis of 27 randomized controlled trials has concluded that testosterone treatment may be effective in reducing depressive symptoms in men, especially when given in higher doses.

^{[13]}A systematic search of Medline, Embase, the Cochrane Central Register of Controlled Trials, and Cumulative Index to Nursing and Allied Health Literature identified 27 randomized control trials.

^{[14]}ResultsOf 39 Cochrane reviews identified, 17 met inclusion criteria (including 168 reports of 127 randomized trials) and the majority (16; 94.

^{[15]}4 years) were treated in the comprehensive cohort design (43 for magnetic resonance imaging‐guided focused ultrasound surgery [27 randomized]; 40 for uterine artery embolization [22 randomized]); baseline clinical and uterine characteristics were similar between treatment arms, except for higher fibroid load in the uterine artery embolization arm.

^{[16]}RESULTS We included 27 randomized controlled trials containing 1925 patients, most with unclear bias risk.

^{[17]}

## 27 randomized controlled

Results: 27 randomized controlled trials (RCTs) were included for analysis (7 evaluating non pharmacologic interventions, 20 pharmacologic therapies).^{[1]}This meta-analysis included 227 randomized controlled.

^{[2]}Forty‐one of 10 132 identified records were included, comprising 6348 participants and 373 outcomes with sample sizes ranging from 10 to 833, including 27 randomized controlled trials (RCTs).

^{[3]}STUDY DESIGN Authors reported primary outcomes from 11 Cochrane systematic reviews (SRs), 12 other SRs, and 327 randomized controlled trials (RCTs).

^{[4]}A total of 27 randomized controlled trials (RCTs), involving 6924 TNBC patients, were included.

^{[5]}Results Overall, 27 randomized controlled trials (RCTs), 1 cluster RCT (cRCT), and 1 quasi-RCT were included in this review.

^{[6]}40 studies (n =5411, mean age 50 to 76 y, 21% to 100% men), including 27 randomized controlled trials (RCTs), met the inclusion criteria.

^{[7]}A systematic review and meta‐analysis of 27 randomized controlled trials has concluded that testosterone treatment may be effective in reducing depressive symptoms in men, especially when given in higher doses.

^{[8]}RESULTS We included 27 randomized controlled trials containing 1925 patients, most with unclear bias risk.

^{[9]}

## 27 randomized control

RESULTS We systematically reviewed 27 randomized control trials (13,356 participants), which compared 12 different antiemetic regimens: serotonin-3 receptor antagonist (5HT3), 5HT3 + dexamethasone (Dex), palonosetron (PAL), PAL + Dex, PAL at 0.^{[1]}A systematic search of Medline, Embase, the Cochrane Central Register of Controlled Trials, and Cumulative Index to Nursing and Allied Health Literature identified 27 randomized control trials.

^{[2]}

## 27 randomized trial

OUTCOMES We found twelve eligible systematic reviews which included between three (143 women) and 27 randomized trials (2093 women).^{[1]}ResultsOf 39 Cochrane reviews identified, 17 met inclusion criteria (including 168 reports of 127 randomized trials) and the majority (16; 94.

^{[2]}